Miragen Therapeutics (NASDAQ:MGEN) initiated with Outperform rating and $13 (52% upside) price target by Oppenheimer.
Humana (NYSE:HUM) upgraded to Buy by Jefferies.
Anthem (NYSE:ANTM) upgraded to Buy by Jefferies.
Aradigm (NASDAQ:ARDM) downgraded to Neutral by Ladenburg Thalmann after negative Ad Com vote on Linhaliq.
Axovant Sciences (NASDAQ:AXON) downgraded to Market Perform by Cowen & Co.
Concert Pharmaceuticals (NASDAQ:CNCE) downgraded to Neutral with a $23 (11% upside) price target by Mizuho Securities.
Lipocine (NASDAQ:LPCN) price target lowered to $3 (60% upside) from $10 by H.C. Wainwright after negative Ad Com vote on TLANDO.
Subscribe for full text news in your inbox